GRASP 2008 Report: Trends in Antimicrobial Resistant Gonorrhoea
Health Protection Agency
Resistance to third-generation cephalosporins, the current recommended first-line treatment for gonorrhoea, is emerging in England and Wales, and the first examples of reduced susceptibility to ceftriaxone were observed in 2008.
An apparent outbreak of high-level resistance to penicillin and tetracycline associated with sexual contact abroad emerged in 2007 and is ongoing in 2008.
Ciprofloxacin resistance is now endemic in England and Wales, accounting for 28% of all isolates tested in 2008.
Treatment of gonorrhoea is likely to become increasingly problematic as new types of resistance emerge.
Last reviewed: 26 January 2012